|
Agenda
Redefining Exclusion/Inclusion Criteria for IV tPA Use will address use of IV tPA in the following situations:
- Mild or rapidly improving symptoms
- Anticoagulants
- Seizures
Learning Objectives
Through participation in this activity, participants should be better able to:
- Discuss the history and background of NINDS’ tPA study criteria
- Evaluate their respective hospital’s protocol for using IV tPA in acute ischemic stroke
- Describe a rationale for modifying current IV tPA treatment protocols
Target Audience
The target audience for this activity are neurologists, neuroscience nurses, emergency department physicians and nurses, and hospitalists.
Accreditation
Statement
This activity has been planned and implemented in accordance with the
Essential Areas and Policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of Medical Education
Resources (MER) and National Stroke Association. MER is accredited by the ACCME
to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Accreditation
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.
For questions regarding this activity, please contact Medical Education Resources at info@mer.org.
Method of Participation
This enduring webinar is designed for individual viewing. The post-test and evaluation are electronic and can only be completed by an individual after watching the program. There are no fees for participating in and receiving credit for this activity.
During the period from June 20, 2012, through July 31, 2013, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the post-test by recording the best answer to each question, 4) complete the evaluation form and 5) click on “Submit” to return to National Stroke Association.
If you are viewing this program in a group, contact Valerie Siebert-Thomas at vsiebert-thomas@stroke.org for more information.
Faculty
Mark J. Alberts, MD
Professor of Neurology
Chief of the Division of Stroke and Cerebrovascular Disease Northwestern
University
Feinberg School of Medicine
Director of the Stroke Program Northwestern Memorial Hospital in Chicago, IL
James C. Grotta, MD
Director, Vascular Neurology Program
Professor and Chairman, Department of Neurology
Roy M. and Phyllis Gough Huffington Distinguished Chair UTHealth Medical School
Arthur Pancioli, MD
Professor and Chairman of the
Department of Emergency Medicine University of Cincinnati
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance,
independence, objectivity, and scientific rigor in all our educational
activities. In accordance with this policy, MER identifies conflicts of
interest with its instructors, content managers, and other individuals who are
in a position to control the content of an activity. Conflicts are resolved by
MER to ensure that all scientific research referred to, reported, or used in a
CME activity conforms to the generally accepted standards of experimental
design, data collection and analysis. MER is committed to providing its
learners with high-quality CME activities that promote improvements or quality
in health care and not the business interest of a commercial interest.
Faculty
Disclosures
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
|
Name of Faculty |
Reported Financial Relationship |
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
|
Name of Content Manager |
Reported Financial Relationship |
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Genentech and Penumbra. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Genentech and Penumbra. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
System
requirements:
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista
or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.
To view MER’s Privacy Policy: http://www.mer.org/privacy_policy
Controversies in Stroke Care Webinar Series
 |
Redefining Inclusion/Exclusion Criteria for IV tPA Use |
|
Rehabilitation for Stroke Patients |
|
Acute Interventions |
The Controversies in Stroke Care webinar series is brought to you by an educational grant from Genentech, Inc. and Penumbra, Inc.
